Author: Laura Yecies

Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care

BHT closes oversubscribed financing round, adds new investors to revolutionize low bone density treatments Redwood City, CA – March 4, 2024 – Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from…
Read more

Osteoboost in the News

Catch up on the latest news coverage of Bone Health Technologies and the breakthrough Osteoboost belt for osteopenia treatment.

Bone Health Technologies Announces FDA Clearance of Osteoboost, the First Prescription Medical Device to Treat Low Bone Density

Redwood City, CA – January 18, 2024 – Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).  Osteoboost is a wearable belt device, worn on the…
Read more

Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women 

First Device to Demonstrate Bone Strength Benefit in Clinical Trial REDWOOD CITY, CA (DEC, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization of the Osteoboost device. Osteoboost has been shown in clinical trials…
Read more

Bone Health Technologies to Present Clinical Data at ASBMR 2023 from Pivotal Trial of Wearable Treatment for Osteopenia in Post-Menopausal Women

Osteoboost Reduced the Loss of Vertebral Bone Strength by 83% in One Year for Per Protocol Participants Vancouver, BC, Canada (October 13, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal trial for the Osteoboost at ASBMR…
Read more